Sergio Ramos has won two leagues with Real Madrid these last ten years. The defender has become the third highest scoring defender in all of LaLiga history, with a total of 66 goals.5. BusquetsSergio Busquets is the midfielder who has played the most minutes in the last decade in La Liga, adding 25,530 minutes. During these years, the player has scored 8 goals and made 25 league assists.FC Barcelona, club in which he has played since 2008, has managed to win six leagues in the last decade.6. EvenThe current Valencia player has played 25,041 minutes in LaLiga the last ten years. He started the 2010/11 season as a Getafe player, with whom he scored 3 goals and 5 assists in the league.In the 2011/12 season he signed for Valencia. Since then, the Valencia captain has scored 53 goals and 49 assists for the club.7. PiquéGerard Piqué has played the last decade with FC Barcelona, and adds 24,716 minutes. During these years, the player has become one of the best defenses in LaLiga.He has achieved 25 goals and 7 assists for the club in the league, and has raised 6 leagues with Barcelona in the last ten years.8. Cristiano RonaldoThe Portuguese striker became the best Real Madrid player of the last decade, for which he added 24,508 minutes disputed. During his career at Real Madrid the last ten years, he has managed two leagues and he has scored 285 league goals and achieved 85 league assists.With Real Madrid he won two leagues in 2013 and 2018. As for personal titles, has achieved four Golden Balls, three Golden Boots, three Pichichi Trophies of the Spanish League and a Player of the Year trophy for the League.Currently, the Portuguese striker plays for Juventus, the club for which he signed this season and with which he has 21 goals.9. GabiThe Spanish midfielder has played for the last decade 24,210 minutes in the league. In the 2010/11 season he played for Zaragoza in the first division, with which he scored 11 goals and achieved 5 assists.After finishing the season, he signed for Atlético de Madrid, with which he managed to win a league in 2014. During his time at Atlético, he has achieved 6 goals and 26 league assists.This season, Gabi signed for Al Sadd, with whom he has played ten games and managed one assist.10. IraizozGorka Iraizoz is the goalkeeper who has played the most minutes during the last decade in LaLiga, reaching the 23,655 minutes disputed.The decade began as an Athletic goalkeeper, with whom he has conceded 293 goals and managed to maintain the clean sheet in 64 games.In the 2017/2018 season, he signed for Girona and played 16 games. It is currently retired.11. KokeThe midfielder has played in the last ten years with Atlético de Madrid, and has added 23,159 minutes. Won their only Spanish league in the 2013/14 season.Koke has managed to score 31 goals and 78 league assists for the club over the past ten years. The Santander League is one of the most powerful and competent league competitions in the world. Many of the best players in history have played in Spain, such as Messi, Di Stéfano, Cristiano Ronaldo or Johan Cruyff. Despite the large number of players who have competed in La Liga, so only the best can stand out and have a long career.The Transfermarkt portal has carried out the eleven of the players who have played the most minutes during the last decade in the Santander League, an eleven that adds up 520 million euros market value. Of the eleven players that appear, seven continue to play in the Spanish league.FC Barcelona highlights, which has four players who currently play for the club at eleven. Atlético de Madrid, Real Madrid and Valencia have a player in eleven.This is the eleven players with the most minutes played in the last decade in LaLiga: 1. Leo MessiThe Barcelona player has played 28,850 minutes in La Liga the last 10 years, in which he has scored 349 goals and 139 assists. During this decade, FC Barcelona has won six leagues.As for the individual awards, the Argentine forward has won six gold boots, six Spanish League Pichichi trophies, six trophies for the best player of the season and six Golden Balls.2. GriezmannThe French striker has disputed 26,701 minutes in the last decade of La Liga. Antoine Grizmann has played on three teams in the last ten years: Real Sociedad, Atlético de Madrid and FC Barcelona.He debuted in the First Division with Real Sociedad in the 2010/11 season. He remained at the Basque club until the 2013/14 season. During these four years, Griezmann scored 47 league goals.In 2014 he signed for Atlético de Madrid, becoming one of the club’s top scorers. He played for five seasons in the Madrid team, with which he scored 114 goals in LaLiga.This last season he signed for FC Barcelona, with which he has 13 goals. This season Griezmann could win his first Spanish league.3. GodínDiego Godín has 26,028 minutes in La Liga since the 2010/11 season, in which he signed for Atlético de Madrid. The Uruguayan became a key defender in Atlético’s eleven. In the season 2013/14 won their only Spanish league. During his time at Atlético the last decade he achieved 17 goals and 10 assists in the league.The Uruguayan defender signed for Inter Milan this season, where he has played 17 games and has made one assist.4. Sergio RamosThe Real Madrid captain has played 25,713 minutes in the Spanish league since 2010. This last decade he has played in the Madrid club, and has become one of the best players in the club, adding 42 goals and 16 assists.
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. Valeant Pharmaceuticals International Inc. and Turing Pharmaceuticals AG, both under congressional investigation over skyrocketing drug prices, were focused on making money before helping patients, members of Congress said internal documents obtained from the companies show. “$1 bn here we come,” former Turing Chief Executive Officer Martin Shkreli said in an e-mail to the chairman of the board on May 27, after the company had made progress toward acquiring the antiparasitic drug Daraprim, according to a memo from House Oversight and Government Reform Committee’s ranking Democrat Elijah Cummingsof Maryland. After buying the drug later that year, Turing raised the price by more than 50-fold, to $750 a pill. (Edney and Bloomfield, 2/2) Bloomberg: Shkreli Says He Wishes He Could ‘Berate,’ ‘Insult’ Congress Bloomberg: Valeant, Shkreli Put Profits Above Patients, Congress Says The House Committee on Oversight and Investigations is looking into Turing and other drug companies’ price increases. [A] memo, released Tuesday, includes excerpts from the company’s internal documents and emails. … The company thought it could handle blowback from AIDS activists and doctors: “HIV patient advocacy may react to price increase … we still come out ahead if we can frame this issue within the HIV/AIDS community as a fight between a drug company and insurance companies. As long as everyone who needs Daraprim can get it as soon as they need it, regardless of ability to pay, the community should have no issue. There is no love lost between HIV/AIDS activists and insurance companies, and they certainly don’t want to be manipulated by them to fight on their behalf.” (Kodjak, 2/2) Former drug executive Martin Shkreli, who is under investigation for securities fraud and the subject of a congressional inquiry, has replaced his legal team with Benjamin Brafman, the same lawyer who helped get rapper Sean “Diddy” Combs acquitted of gun and bribery charges in 2001. The New York-based lawyer confirmed in an e-mail that he is representing Shkreli. Brafman’s client list also includes Dominique Strauss-Kahn, Michael Jackson, Gambino crime family underboss Salvatore “Sammy the Bull” Gravano, rapper Jay Z and former New York Giants wide receiver Plaxico Burress. Shkreli announced the legal change during an interview with Fox Business Network on Tuesday. (Edney, 2/2) The Washington Post’s Wonkblog: How Pharma Bro Martin Shkreli Described His Own Drug Price Hike: ‘Almost All Of It Is Profit.’ A number of pharmaceutical companies have raised the prices of drugs after acquiring the rights to sell them in the U.S., a tactic that some Wall Street analysts say is contributing to higher spending on prescription medicines and has prompted criticism of price gouging. From 2014 to 2015, Valeant raised the price of more than 20 prescription products by more than 200%, [congressional] Democrats’ memos say. The company increased the prices of several of these products in some cases by as much as 800%, according to the memos. (Armour and Rockoff, 2/2) The Associated Press: Congress: Drugmakers Planned Price Hikes To Boost Profits Two drugmakers have made a practice of buying and then dramatically hiking the prices of low-cost drugs given to patients with life-threatening conditions including heart disease, AIDS and cancer, according to excerpts from thousands of documents released by federal lawmakers. Rep. Elijah Cummings, D-Maryland, released the information Tuesday ahead of a hearing Thursday to examine exorbitant price spikes. Cummings has used his position atop the House Committee on Oversight and Government Reform to investigate several companies that have bought previously low-cost drugs and jacked up their prices many times over. (2/2) The Wall Street Journal: Valeant, Turing Boosted Drug Prices To Fuel Preset Profits NPR: A Peek Inside Turing Pharmaceuticals: ‘Another $7.2 Million. Pow!’ In late May of last year, Turing Pharmaceuticals, then a little-known drug company, was nearing a deal to acquire Daraprim, a 62-year-old drug that fights a rare but severe parasitic infection. “Very good. Nice work as usual,” the company’s young chief executive, Martin Shkreli, wrote to the chairman of the board. “$1 bn here we come.” In August, he wrote to someone outside the company that hiking the price of the drug would bring in $375 million a year — “almost all of it is profit,” which he predicted would continue for three years. (Johnson, 2/2) The New York Times: Martin Shkreli All But Gloated Over Huge Drug Price Increases, Memos Show ‘$1B Here We Come’: Congressional Memos Expose Shkreli’s Emails About Price Hikes Ahead of Thursday’s House Oversight and Government Reform Committee hearing on drug costs, congressional Democrats release documents from former Turing CEO Martin Shkreli and others that reveal how the company planned to maximize profits and control public perception. Martin Shkreli anticipated huge profits from raising the price of a decades-old drug for an infectious disease, belying any notion that helping patients was foremost in his mind, according to information released by congressional investigators on Tuesday. The investigators also provided evidence showing that Valeant Pharmaceuticals International carefully pondered how much it could raise the price of two old heart drugs, Isuprel and Nitropress, before buying them a year ago and increasing their prices overnight, by 525 percent for Isuprel and 212 percent for Nitropress. (Pollack and Goldstein, 2/2)